Active substancePancreatinPancreatin
Similar drugsTo uncover
  • Gastenorm forte
    pills inwards 
  • Gastenorm forte 10000
    pills inwards 
  • Creon® 10000
    capsules inwards 
  • Creon® 25000
    capsules inwards 
  • Creon® 40000
    capsules inwards 
  • Creon® Micro
    granules inwards 
  • Mezim® 20000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte 10000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Pangrol® 25000
    capsules inwards 
  • PanziKam
    pills inwards 
    CAMELIA NPP, LLC     Russia
  • Panzim® forte
    pills inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Pancreatic
    pills inwards 
    TECHNOLOG, JSC     Ukraine
  • Pancreatin
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Pancreatin
    pills inwards 
  • Pancreatin
    pills inwards 
    AVEKSIMA, JSC     Russia
  • Pancreatin
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Pancreatin
    pills inwards 
    FARMPROJECT, CJSC     Russia
  • Pancreatin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin forte
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin-LekT
    pills inwards 
  • Penzital
    pills inwards 
  • Enzistal®-P
    pills inwards 
  • Hermitage®
    capsules inwards 
  • Dosage form: & nbspenteric coated tablets
    Composition:

    Composition per one tablet

    Active substance: pancreatin - 0.1 g (proteolytic activity is not less than - 25 U, lipolytic activity is not less than - 140 units, amylolytic activity is not less than 1500 units).

    Excipients: lactose milk) - 0.2120 g, methyl cellulose MC-16 - 0.0048 g, calcium stearate - 0.0032 g; composition of the shell: celllife - 0,01386 g, acid red 2C - 0,00010 g, titanium dioxide grade A-1 - 0,00100 g, polysorbate-80 - 0,00006 g.

    Description:

    The tablets covered with a cover, pink or dark pink color, round, biconcave, with a specific smell. The cross-section of the tablet core is allowed to have inclusions.

    Pharmacotherapeutic group:digestive enzyme.
    ATX: & nbsp

    A.09.A.A   Enzyme preparations

    A.09.A.A.02   Pancreatin

    Pharmacodynamics:Replenishment of the deficiency of pancreatic enzymes. Contains excretory pancreatic enzymes: lipase, alpha-amylase, trypsin, chymotrypsin, promotes the breakdown of proteins (up to amino acids), fats (up to glycerol and fatty acids) and starch (to dextrins and monosaccharides), normalizes the digestive process. Enzymes, which are part of pancreatin, are released in the alkaline environment of the small intestine, tk. protected from the action of gastric juice shell. Trypsin in the upper part of the small intestine inhibits the stimulated secretion of the pancreas, causing an analgesic effect of pancreatin.
    Indications:

    Applied with achilia, chronic pancreatitis with insufficient pancreatic function, with digestive disorders associated with liver and pancreas diseases, anacid and hypatid gastritis, chronic enterocolitis.

    Contraindications:

    Hypersensitivity (including pork intolerance), acute pancreatitis, exacerbation of chronic pancreatitis.

    Dosing and Administration:

    Tablets are taken with food or immediately after it, without cracking. For adults, a single dose of pancreatin is 0.5-1.0 g, daily - 4 g.

    Children under the age of 1 year pancreatin in powder designate 0.1-0.15 g, 2 years-0.2 g, 3-4 years-0.25 g, 5-6 years -0.3 g, 7-9 years-0.4 grams , 10-14 years -0.5 g at the reception.The drug is prescribed in tablets children in the following doses: at the age of 6-7 years 1 tablet (0.25 g), 8-9 years 1-2 tablets (0.25-0.5 g), 10-14 years 2 tablets (0.5 g ).

    The course of treatment is from 4-6 weeks to 2-3 months or more.

    Side effects:

    Symptoms of intestinal obstruction (the formation of strictures in the ileocecal and ascending colon) and allergic reactions of immediate type (in cystic fibrosis, especially in children).

    Interaction:

    Reduces absorption of iron (especially with prolonged use).

    Form release / dosage:Tablets coated with enteric coating 25 units.
    Packaging:

    These sections are specified in the Instruction on Medical Use for Preparations Produced by OAO Irbitsky Chemical Pharmaceutical Plant.

    10 tablets per contour cell packaging made of polyvinylchloride film and aluminum foil. For 60 tablets in a jar of orange glass, ukuporennyh pulled plastic caps or a jar of polymer materials with a screw cap. Free space in the bank is filled with cotton wool or a polyethylene seal. On the bank paste a label from paper label or writing, or self-adhesive.6 contour mesh packages or a jar with instructions for use are placed in a pack of cardboard box.
    These sections are specified in the Instruction for medical use for preparations manufactured at Anzhero-Sudzhensky Chemical-Pharmaceutical Plant LLC.
    10 tablets per contour cell pack.
    For 60 tablets in a jar of polymer materials.
    For 2 or 6 contour squares or 1 jar with instructions for medical use are placed in a pack of cardboard.
    Storage conditions:Store in a dry place at a temperature of 12 to 20 ° C.
    Keep out of the reach of children.
    Shelf life:2 years. After expiration date the drug should not be used.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-002153/08
    Date of registration:28.03.2008
    The owner of the registration certificate:AVEKSIMA, JSC AVEKSIMA, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp19.08.2015
    Illustrated instructions
      Instructions
      Up